English

Brighter’s Nomination Committee for the Annual Shareholders’ Meeting 2021

Report this content

Brighter’s Nomination Committee for the Annual Shareholders’ Meeting 2021 has been appointed based on the ownership structure as of 30 September 2020 in line with the nomination committee instruction that was adopted at the 2020 Annual General Meeting. The Nomination Committee shall consist of Brighter’s Chairperson of the Board and representatives of the three largest shareholders. If any shareholder waives their right to nominate a representative, the shareholder next in order, in relation to the number of votes, shall be offered to nominate a representative. For full details regarding the nomination committee instruction, please see the complete proposal that was adopted on the 2020 Annual General Meeting here: Item 13 – Proposal for resolution on nomination committee instruction.

The Nomination Committee for the AGM 2021 consists of:

  • Brighter’s Chairperson of the Board
  • Carl-Adam Drakenberg
  • Nino Armoni
  • Truls Sjöstedt

The Nomination Committee shall prepare proposals on the following matters: (a) proposal for board directors, (b) proposal for auditor, (c) proposal for chair of the board, (d) proposal for remuneration to be paid to the directors, the chair of the board and remuneration for work in the committees, (e) proposal for remuneration to the auditor, (f) proposal for a chair of the annual general meeting and (g) a new instruction to the nomination committee if deemed necessary.

Shareholders who wish to submit proposals to the nomination committee for the Annual General Meeting on 17 May 2021 can do so by email to nomination2021@brighter.se. Proposals should be submitted to the nomination committee before 1 March 2021.

For further information, please contact:

Investor Relations
IR@brighter.se

Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

Documents & Links